Simrat Randhawa - EVP, Head of R&D at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Head of R&D
Issuer Symbol
DNTH on Nasdaq
All Insider Reports
All Insider Reports

Simrat Randhawa - trading volume in the past year for Dianthus Therapeutics, Inc. /DE/

Holdings reported by Simrat Randhawa for Dianthus Therapeutics, Inc. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,000 $152,560 $38.14 14 Nov 2025 Direct
Stock Option (Right to Buy) 150,000 03 Feb 2026 Direct Common Stock

Transactions reported by Simrat Randhawa for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.